B-Lymphocyte Subpopulations in Patients With Rheumatoid Arthritis and the Effect of an Interleukin-6 Receptor Inhibitor on Them.

Nauchno-Prakticheskaya Revmatologiya - Russian Federation
doi 10.14412/1995-4484-2018-731-738
Full Text
Abstract

Available in full text

Date
Authors
Publisher

IMA Press, LLC

Related search

Interleukin-6 Inhibition and Cardiovascular Disease in Patients With Rheumatoid Arthritis

Terapevticheskii Arkhiv
Internal MedicineEndocrinologyMetabolismDiabetes
2016English

Inhibitor of Biological Effects of Interleukin-6 Sarilumab in Treatment of Rheumatoid Arthritis

Medical Council
2019English

Blockade of Interleukin 6 Signaling Induces Marked Neutropenia in Patients With Rheumatoid Arthritis

Journal of Rheumatology
RheumatologyAllergyImmunology
2009English

T-Lymphocyte Interleukin 6 Receptor Binding in Patients With Dementia of Alzheimer Type

Archives of Neurology
1998English

Rosuvastatin for Tocilizumab, an Interleukin-6 Receptor Antibody-Induced Dyslipidemia in a Diabetic Patient Complicated With Rheumatoid Arthritis

Journal of Endocrinology and Metabolism
EndocrinologyMetabolismDiabetes
2011English

SAT0209 Observational Study on the Effects of Il-6 Inhibitor Therapy on Myostatin in Patients With Rheumatoid Arthritis

2017English

The Importance of Interleukin 6 Inhibition in Juvenil Rheumatoid Arthritis

The Bulletin of Contemporary Clinical Medicine
2020English

An Inhibitor of Leucocyte Movement in the Plasma of Patients With Rheumatoid Arthritis.

Annals of the Rheumatic Diseases
ImmunologyMolecular BiologyBiochemistryRheumatologyAllergyGenetics
1980English

Tocilizumab, a Humanized Anti-Interleukin-6 Receptor Antibody, for Treatment of Rheumatoid Arthritis

Open Access Rheumatology: Research and Reviews
Rheumatology
2011English

Amanote Research

Note-taking for researchers

Follow Amanote

© 2024 Amaplex Software S.P.R.L. All rights reserved.

Privacy PolicyRefund Policy